Literature DB >> 1730635

Maxadilan. Cloning and functional expression of the gene encoding this potent vasodilator peptide.

E A Lerner1, C B Shoemaker.   

Abstract

Maxadilan is a potent vasodilator peptide released into the skin when the sand fly Lutzomyia longipalpis, an important vector of leishmania, probes for a blood meal. As several lines of evidence suggest that this peptide may play a critical role in the enhancement of leishmania infectivity attributed to sand fly saliva, the peptide has been proposed as a candidate antigen for a leishmanial vaccine. Although maxadilan is the most potent vasodilator peptide known and shares several properties with calcitonin gene-related peptide (CGRP), studies of its structure, physiological effects, and biological roles have been limited by the miniscule quantities available. Here we report the isolation of cDNA and genomic DNA clones that encode maxadilan. The predicted translation product shows no significant homology with any previously isolated proteins. The coding DNA has been expressed in Escherichia coli and the purified recombinant peptide is biologically active with a specific activity comparable to the natural peptide. Recombinant maxadilan will be useful in studies of vascular biology and could lead to novel therapeutic and prophylactic agents.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1730635

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

Review 1.  An insight into the sialome of blood-feeding Nematocera.

Authors:  José M C Ribeiro; Ben J Mans; Bruno Arcà
Journal:  Insect Biochem Mol Biol       Date:  2010-08-20       Impact factor: 4.714

2.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1992-04-25       Impact factor: 16.971

Review 3.  Maxadilan, a PAC1 receptor agonist from sand flies.

Authors:  Ethan A Lerner; Aurel O Iuga; Vemuri B Reddy
Journal:  Peptides       Date:  2007-06-28       Impact factor: 3.750

4.  Toward an understanding of the biochemical and pharmacological complexity of the saliva of a hematophagous sand fly Lutzomyia longipalpis.

Authors:  R Charlab; J G Valenzuela; E D Rowton; J M Ribeiro
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

5.  Maxadilan, the Lutzomyia longipalpis vasodilator, drives plasma leakage via PAC1-CXCR1/2-pathway.

Authors:  Erik Svensjö; Elvira M Saraiva; Rafael Silveira Amendola; Christina Barja-Fidalgo; Marcelo T Bozza; Ethan A Lerner; Mauro M Teixeira; Julio Scharfstein
Journal:  Microvasc Res       Date:  2011-10-19       Impact factor: 3.514

6.  Antibodies from dogs with canine visceral leishmaniasis recognise two proteins from the saliva of Lutzomyia longipalpis.

Authors:  Diana Bahia; Nelder Figueiredo Gontijo; Ileana Rodríguez León; Jonas Perales; Marcos Horácio Pereira; Guilherme Oliveira; Rodrigo Corrêa-Oliveira; Alexandre Barbosa Reis
Journal:  Parasitol Res       Date:  2006-10-21       Impact factor: 2.289

7.  Salivary gland extracts from the deerfly contain a potent inhibitor of platelet aggregation.

Authors:  S A Grevelink; D E Youssef; J Loscalzo; E A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

8.  VIP and PACAP effects on mouse major pelvic ganglia neurons.

Authors:  John D Tompkins; Beatrice M Girard; Margaret A Vizzard; Rodney L Parsons
Journal:  J Mol Neurosci       Date:  2010-04-29       Impact factor: 3.444

9.  Differential activation of guinea pig intrinsic cardiac neurons by the PAC1 agonists maxadilan and pituitary adenylate cyclase-activating polypeptide 27 (PACAP27).

Authors:  Donald B Hoover; John D Tompkins; Rodney L Parsons
Journal:  J Pharmacol Exp Ther       Date:  2009-07-14       Impact factor: 4.030

10.  Sialokinin I and II: vasodilatory tachykinins from the yellow fever mosquito Aedes aegypti.

Authors:  D E Champagne; J M Ribeiro
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.